480 related articles for article (PubMed ID: 32781585)
1. Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.
Valtorta S; Salvatore D; Rainone P; Belloli S; Bertoli G; Moresco RM
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781585
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
3. Top-down stepwise refinement identifies coding and noncoding RNA-associated epigenetic regulatory maps in malignant glioma.
Huang Y; Gao X; Yang E; Yue K; Cao Y; Zhao B; Zhang H; Dai S; Zhang L; Luo P; Jiang X
J Cell Mol Med; 2022 Apr; 26(8):2230-2250. PubMed ID: 35194922
[TBL] [Abstract][Full Text] [Related]
4. MiR-181b sensitizes glioma cells to teniposide by targeting MDM2.
Sun YC; Wang J; Guo CC; Sai K; Wang J; Chen FR; Yang QY; Chen YS; Wang J; To TS; Zhang ZP; Mu YG; Chen ZP
BMC Cancer; 2014 Aug; 14():611. PubMed ID: 25151861
[TBL] [Abstract][Full Text] [Related]
5. The emergent role of exosomes in glioma.
Gourlay J; Morokoff AP; Luwor RB; Zhu HJ; Kaye AH; Stylli SS
J Clin Neurosci; 2017 Jan; 35():13-23. PubMed ID: 27771233
[TBL] [Abstract][Full Text] [Related]
6. Identification of PIEZO1 as a potential prognostic marker in gliomas.
Zhou W; Liu X; van Wijnbergen JWM; Yuan L; Liu Y; Zhang C; Jia W
Sci Rep; 2020 Sep; 10(1):16121. PubMed ID: 32999349
[TBL] [Abstract][Full Text] [Related]
7. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
Chen J; Hou C; Wang P; Yang Y; Zhou D
World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
[TBL] [Abstract][Full Text] [Related]
8. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis.
Ghaemmaghami AB; Mahjoubin-Tehran M; Movahedpour A; Morshedi K; Sheida A; Taghavi SP; Mirzaei H; Hamblin MR
Cell Commun Signal; 2020 Aug; 18(1):120. PubMed ID: 32746854
[TBL] [Abstract][Full Text] [Related]
9. MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells.
Wang L; Su J; Zhao Z; Hou Y; Yin X; Zheng N; Zhou X; Yan J; Xia J; Wang Z
Cell Cycle; 2017 Oct; 16(20):1954-1964. PubMed ID: 28898169
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
Ait Ssi S; Chraa D; El Azhary K; Sahraoui S; Olive D; Badou A
Front Immunol; 2021; 12():685213. PubMed ID: 34539626
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B
Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592
[TBL] [Abstract][Full Text] [Related]
12. Imaging of the glioma microenvironment by TSPO PET.
Zinnhardt B; Roncaroli F; Foray C; Agushi E; Osrah B; Hugon G; Jacobs AH; Winkeler A
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):174-185. PubMed ID: 33721063
[TBL] [Abstract][Full Text] [Related]
13. Current landscape of tumor-derived exosomal ncRNAs in glioma progression, detection, and drug resistance.
He X; Qi Y; Zhang X; Liu X; Li X; Li S; Wu Y; Zhang Q
Cell Death Dis; 2021 Dec; 12(12):1145. PubMed ID: 34887381
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1.
Chen G; Chen Z; Zhao H
J Cell Mol Med; 2020 May; 24(9):5363-5374. PubMed ID: 32220051
[TBL] [Abstract][Full Text] [Related]
15. Progress in the study of markers related to glioma prognosis.
Luo Y; Hou WT; Zeng L; Li ZP; Ge W; Yi C; Kang JP; Li WM; Wang F; Wu DB; Wang RY; Qu BL; Li XF; Wang JJ
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7690-7697. PubMed ID: 32744695
[TBL] [Abstract][Full Text] [Related]
16. Regulatory interplay between microRNAs and WNT pathway in glioma.
Tabnak P; Mafakheri A; Haji Emsailpoor Z; Kazemi T; Shekari N
Biomed Pharmacother; 2021 Nov; 143():112187. PubMed ID: 34560532
[TBL] [Abstract][Full Text] [Related]
17. Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.
Shiraki Y; Mii S; Enomoto A; Momota H; Han YP; Kato T; Ushida K; Kato A; Asai N; Murakumo Y; Aoki K; Suzuki H; Ohka F; Wakabayashi T; Todo T; Ogawa S; Natsume A; Takahashi M
J Pathol; 2017 Dec; 243(4):468-480. PubMed ID: 28888050
[TBL] [Abstract][Full Text] [Related]
18. Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model.
Lo Dico A; Martelli C; Valtorta S; Raccagni I; Diceglie C; Belloli S; Gianelli U; Vaira V; Politi LS; Bosari S; Lucignani G; Moresco RM; Ottobrini L
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1093-105. PubMed ID: 25813354
[TBL] [Abstract][Full Text] [Related]
19. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
20. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
